Bloomberg News

Fresenius Wins U.S. Appeal Over Baxter Hemodialysis Patent

July 02, 2013

Fresenius Medical Care AG won a U.S. appeals court ruling today that will end a patent-infringement claim brought against it by Baxter International Inc. (BAX:US) over kidney dialysis machines.

The U.S. Patent and Trademark Office has canceled the Baxter patent after a review while the civil suit was still pending, so there is no longer any basis for Baxter’s claim, the U.S. Court of Appeals for the Federal Circuit ruled in Washington today. The opinion was posted on the court’s website.

To contact the reporter on this story: Susan Decker in Washington at sdecker1@bloomberg.net

To contact the editor responsible for this story: Bernard Kohn at bkohn2@bloomberg.net


Best LBO Ever
LIMITED-TIME OFFER SUBSCRIBE NOW

Companies Mentioned

  • BAX
    (Baxter International Inc)
    • $72.65 USD
    • -2.34
    • -3.22%
Market data is delayed at least 15 minutes.
 
blog comments powered by Disqus